Top experts by indication / Respiratory
Most active experts in Idiopathic Pulmonary Fibrosis
2026 edition, data as of October 26, 2026
284 key opinion leaders in the directory are tagged to Idiopathic Pulmonary Fibrosis. The tables below rank them by one public measure each: registered trials, citations, NIH awards and congress contributions. Each is a count from a named source, not a judgment about the person, and every row links a profile where the count can be checked.
Most registered trials
Registered clinical trials in this indication on which the person is a listed investigator, counted from ClinicalTrials.gov. 64 of the 284 people tagged to this indication have this count on record; the 25 highest are listed. Source: ClinicalTrials.gov.
| # | Expert | trials |
|---|---|---|
| 1 | Fernando MartinezUniversity of Massachusetts Chan Medical School, MA | 10 trials |
| 2 | Toby MaherKeck School of Medicine of the University of Southern California (USC), CA | 8 trials |
| 3 | Ganesh RaghuUniversity of Washington Medical Center, WA | 7 trials |
| 4 | Mary ScholandHuntsman Cancer Institute, University of Utah, UT | 7 trials |
| 5 | Imre NothUniversity of Virginia School of Medicine, VA | 7 trials |
| 6 | Maria PadillaIcahn School of Medicine at Mount Sinai, NY | 6 trials |
| 7 | Kevin FlahertyUniversity of Michigan, MI | 5 trials |
| 8 | Lake MorrisonDuke University School of Medicine, NC | 5 trials |
| 9 | David ZismanCleveland Clinic, FL | 5 trials |
| 10 | Danielle Antin-OzerkisYale School of Medicine, CT | 4 trials |
| 11 | Joel MossNational Institutes of Health, MD | 4 trials |
| 12 | Rajan SaggarUniversity of California, Los Angeles, CA | 4 trials |
| 13 | Jesse RomanThomas Jefferson University, GA | 4 trials |
| 14 | Lisa LancasterEndeavor BioMedicines, TN | 4 trials |
| 15 | James LoydTN | 3 trials |
| 16 | Talmadge KingUniversity of California, San Francisco, CA | 3 trials |
| 17 | Yolanda MagetoBaylor University Medical Center at Dallas, TX | 3 trials |
| 18 | Maureen HortonUnknown current institutional affiliation, CA | 3 trials |
| 19 | Kevin BrownNational Cancer Institute, CO | 3 trials |
| 20 | Gerard CrinerTemple University, PA | 3 trials |
| 21 | Marilyn GlassbergLoyola University Chicago Stritch School of Medicine, IL | 3 trials |
| 22 | Ronald CrystalWeill Cornell Medicine, NY | 3 trials |
| 23 | John BelperioUniversity of California, Los Angeles, CA | 3 trials |
| 24 | Tanzira ZamanCedars-Sinai Medical Center, CA | 2 trials |
| 25 | Gail WeinmannNational Heart, MD | 2 trials |
Most cited
Citations to the person's whole published record in OpenAlex, not only their work in this indication, among the people with at least two registered trials in it. 26 of the 284 people tagged to this indication have at least 2 registered trials in it and this count on record; the 25 highest are listed. Source: OpenAlex.
| # | Expert | citations |
|---|---|---|
| 1 | Fernando MartinezUniversity of Massachusetts Chan Medical School, MA | 141,679 citations |
| 2 | Ronald CrystalWeill Cornell Medicine, NY | 86,411 citations |
| 3 | Ganesh RaghuUniversity of Washington Medical Center, WA | 71,831 citations |
| 4 | Talmadge KingUniversity of California, San Francisco, CA | 57,956 citations |
| 5 | Kevin BrownNational Cancer Institute, CO | 55,052 citations |
| 6 | Gerard CrinerTemple University, PA | 54,926 citations |
| 7 | Joel MossNational Institutes of Health, MD | 42,732 citations |
| 8 | Toby MaherKeck School of Medicine of the University of Southern California (USC), CA | 35,184 citations |
| 9 | Kevin FlahertyUniversity of Michigan, MI | 27,421 citations |
| 10 | John BelperioUniversity of California, Los Angeles, CA | 21,088 citations |
| 11 | Lisa LancasterEndeavor BioMedicines, TN | 17,874 citations |
| 12 | Imre NothUniversity of Virginia School of Medicine, VA | 16,369 citations |
| 13 | Jesse RomanThomas Jefferson University, GA | 14,016 citations |
| 14 | Marilyn GlassbergLoyola University Chicago Stritch School of Medicine, IL | 12,905 citations |
| 15 | Maureen HortonUnknown current institutional affiliation, CA | 9,648 citations |
| 16 | Rajan SaggarUniversity of California, Los Angeles, CA | 8,466 citations |
| 17 | Mary ScholandHuntsman Cancer Institute, University of Utah, UT | 7,720 citations |
| 18 | Yolanda MagetoBaylor University Medical Center at Dallas, TX | 4,267 citations |
| 19 | Maria PadillaIcahn School of Medicine at Mount Sinai, NY | 4,056 citations |
| 20 | Ubaldo MartinPA | 4,019 citations |
| 21 | Lake MorrisonDuke University School of Medicine, NC | 3,869 citations |
| 22 | Danielle Antin-OzerkisYale School of Medicine, CT | 3,258 citations |
| 23 | Gail WeinmannNational Heart, MD | 2,996 citations |
| 24 | Robert TigheDuke University, NC | 2,325 citations |
| 25 | Parth RaliTemple University Hospital, PA | 2,280 citations |
Most NIH awards
NIH awards on the person's record in NIH RePORTER, across all of their funded work, among the people with at least two registered trials in this indication. 16 of the 284 people tagged to this indication have at least 2 registered trials in it and this count on record; the 16 highest are listed. Source: NIH RePORTER.
| # | Expert | awards |
|---|---|---|
| 1 | Ronald CrystalWeill Cornell Medicine, NY | 51 awards |
| 2 | James LoydTN | 10 awards |
| 3 | Jesse RomanThomas Jefferson University, GA | 9 awards |
| 4 | Kevin FlahertyUniversity of Michigan, MI | 8 awards |
| 5 | John BelperioUniversity of California, Los Angeles, CA | 7 awards |
| 6 | Gerard CrinerTemple University, PA | 5 awards |
| 7 | Robert TigheDuke University, NC | 4 awards |
| 8 | Ganesh RaghuUniversity of Washington Medical Center, WA | 3 awards |
| 9 | Kevin BrownNational Cancer Institute, CO | 3 awards |
| 10 | Fernando MartinezUniversity of Massachusetts Chan Medical School, MA | 3 awards |
| 11 | Gail WeinmannNational Heart, MD | 2 awards |
| 12 | Imre NothUniversity of Virginia School of Medicine, VA | 2 awards |
| 13 | Talmadge KingUniversity of California, San Francisco, CA | 1 award |
| 14 | Maria PadillaIcahn School of Medicine at Mount Sinai, NY | 1 award |
| 15 | Toby MaherKeck School of Medicine of the University of Southern California (USC), CA | 1 award |
| 16 | Lisa LancasterEndeavor BioMedicines, TN | 1 award |
Most congress contributions
Congress abstracts and presentations attributed to the person and verified by DOI, across every meeting the directory tracks, among the people with at least two registered trials in this indication. 6 of the 284 people tagged to this indication have at least 2 registered trials in it and this count on record; the 6 highest are listed. Source: Congress abstracts, DOI-verified.
| # | Expert | contributions |
|---|---|---|
| 1 | Kevin BrownNational Cancer Institute, CO | 20 contributions |
| 2 | Joel MossNational Institutes of Health, MD | 7 contributions |
| 3 | Ronald CrystalWeill Cornell Medicine, NY | 3 contributions |
| 4 | Gerard CrinerTemple University, PA | 2 contributions |
| 5 | Toby MaherKeck School of Medicine of the University of Southern California (USC), CA | 2 contributions |
| 6 | Rajan SaggarUniversity of California, Los Angeles, CA | 1 contribution |
Emerging
19 of the 284 carry the Emerging flag: publication and trial activity rising over the recent three years, in the top ten percent for growth among specialty peers at a similar career stage. Listed A to Z, not ranked; the flag is a yes or nothing, never a score. How the flag is computed.
| Dana AschermanUniversity of Miami, FL |
| Rene BermeaHarvard University, MA |
| Grant CannonHuntsman Cancer Institute, University of Utah, UT |
| Saadia FaizThe University of Texas MD Anderson Cancer Center, TX |
| Wigdan FarahMayo Clinic, MN |
| Jane FazioUniversity of California, Los Angeles, CA |
| Bhavika KaulMichael E. DeBakey VA Medical Center, TX |
| Ryan KernMayo Clinic, MN |
| Gary KunkelHuntsman Cancer Institute, University of Utah, UT |
| Fabien MaldonadoVanderbilt University Medical Center, TN |
| Asher MarksYale School of Medicine, CT |
| Eva OtoupalovaVA |
| Anthony SalehWeill Cornell Medicine, NY |
| Lynn SchnappUniversity of Wisconsin–Madison, WI |
| Saumini SrinivasanUniversity of Michigan, MI |
| Angela SuenUniversity of California, San Francisco, CA |
| Laszlo VaszarAZ |
| Janine VintchUniversity of California, Los Angeles, CA |
| David ZismanCleveland Clinic, FL |
How these tables are computed
The cohort is every profile in the directory tagged to Idiopathic Pulmonary Fibrosis, from the person's registered trials and published research. Only indications with at least 200 tagged people get a page; a smaller cohort would say more about the tag than about the people in it. Each table sorts the cohort by one count, highest first, with no weighting, no blending and no editorial pass. Ties are broken by the profile's stable internal id so the same counts always give the same order. A person with no count on record is left out of that table, not ranked last.
Citations, NIH awards and congress contributions are counts over a person's whole record, not their work in this indication alone, so those three tables are limited to the indication's investigators: people with at least 2 registered trials in it. Without that rule the most cited people in a cohort are the ones whose careers span many diseases, which is a fact about their careers, not about this field. The registered-trials table is the indication-scoped count itself and has no such limit.
The counts are recomputed on every publish and the page carries the date of the publish it was built from. Previous editions are superseded, not archived.
What is deliberately absent
Reported industry payments are on every profile but are not a table here: a count of payers is a fact, and ranking people by it reads as a judgment. Prescribing volume is part of the paid workspace. The directory's influence tier is a judgment and never orders a public page. Sources and methodology.
Filter, sort and open every Idiopathic Pulmonary Fibrosis profile in the directory